<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">339789</id>
  <title nil="true"/>
  <common-name>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[2-(ethylamino)-2-sulfanylideneethylidene]amino]acetamide</common-name>
  <description>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[2-(ethylamino)-2-sulfanylideneethylidene]amino]acetamide is a chemical compound with the formula C24H28N6OS2. It has an average molecular weight of 480.70 g/mol.</description>
  <cas>303107-27-9</cas>
  <pubchem-id>9656124</pubchem-id>
  <chemical-formula>C24H28N6OS2</chemical-formula>
  <weight>480.7</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T23:10:39Z</created-at>
  <updated-at type="dateTime">2026-08-30T23:10:39Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCNC(=S)C=NNC(=O)CSC1=NN=C(N1C2=CC=CC=C2)C3=CC=C(C=C3)C(C)(C)C</moldb-smiles>
  <moldb-formula>C24H28N6OS2</moldb-formula>
  <moldb-inchi>InChI=1S/C24H28N6OS2/c1-5-25-21(32)15-26-27-20(31)16-33-23-29-28-22(30(23)19-9-7-6-8-10-19)17-11-13-18(14-12-17)24(2,3)4/h6-15H,5,16H2,1-4H3,(H,25,32)(H,27,31)/b26-15+</moldb-inchi>
  <moldb-inchikey>TZMKBESBYLOTAC-CVKSISIWSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">480.1766019</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM335682</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[2-(ethylamino)-2-sulfanylideneethylidene]amino]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0290207</sync-id>
  <structure-inchikey>TZMKBESBYLOTAC-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800000404000220000800040022800000000000000000004000000000000000000000002000002000004008000002084800000100000000000000000200000000000000000000000000000000000000020000000000200000004000010000000000000010000000000000000000000800000000100000000000000000000000000004040000000800000000000000080880000010100000000000000000000000000000000001000000000080000000040000000400000000000002c00000000000800004000000000008000000000400000000800002200000200000000020000000040000000001048000000000400000000010000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAIwAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:40:13Z</structure-indexed-at>
</compound>
